drugset / Trial / NCT02638597

Gemfibrozil for Nicotine Smoking Cessation

NCT02638597

Phase 2 Completed 16 enrolled University of Texas Southwestern Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

This project will test whether gemfibrozil, a well-studied medication for high cholesterol, will help people stop smoking nicotine cigarette smoking. The study will also test whether gemfibrozil decrease cravings for cigarette and the desire to smoke.

Timeline

Start
2015-02
Primary completion
2016-12-23
Completion
2016-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemfibrozil Small molecule 600 mg Oral

Indications

No indication recorded.